Medullary Thyroid Cancer: Molecular Biology and Novel Molecular Therapies

Publisher： Karger

E-ISSN： 1423-0194|90|4|323-348

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.90, Iss.4, 2009-05, pp. : 323-348

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

2012 European Thyroid Association Guidelines for Metastatic Medullary Thyroid Cancer Urge Restrained Use of Novel Kinase Inhibitors

By  

European Thyroid Journal, Vol. 1, Iss. 1, 2012-03 ,pp. : 3-4

Karger

Access to resources Recommend Favorite

Development and Application of a Novel Sensitive Immunometric Assay for Calcitonin in a Large Cohort of Patients with Medullary and Differentiated Thyroid Cancer, Thyroid Nodules, and Autoimmune Thyroid Diseases

By  

European Thyroid Journal, Vol. 3, Iss. 2, 2014-06 ,pp. : 117-124

Karger

Access to resources Recommend Favorite

2012 European Thyroid Association Guidelines for Metastatic Medullary Thyroid Cancer

By  

European Thyroid Journal, Vol. 1, Iss. 1, 2012-03 ,pp. : 5-14

Karger

Access to resources Recommend Favorite

Molecular Mechanisms of Thyroid Dysgenesis

By  

Hormone Research in Paediatrics, Vol. 62, Iss. 3, 2004-11 ,pp. : 14-21

Karger

Access to resources Recommend Favorite

Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer

By  

European Thyroid Journal, Vol. 5, Iss. 3, 2016-09 ,pp. : 187-194

Karger

Access to resources Recommend Favorite